Stuart P. Romeril
25 works · 2,098 citations · h-index 11
Top works
- On the Mechanism of the Palladium(II)-Catalyzed Decarboxylative Olefination of Arene Carboxylic Acids. Crystallographic Characterization of Non-Phosphine Palladium(II) Intermediates and Observation of Their Stepwise Transformation in Heck-like Processes
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2
- Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
- Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
- Structure-Based Design of Potent and Selective 3-Phosphoinositide-Dependent Kinase-1 (PDK1) Inhibitors
- Synthesis of a possible structure of pyrinodemin A
- Studies toward the Total Synthesis of the Cytotoxic Sponge Alkaloid Pyrinodemin A
- Investigation into the absolute stereochemistry of the marine sponge alkaloid pyrinodemin A
- Synthesis of marine sponge alkaloid hachijodine B and a comment on the structure of ikimine B and on the absolute configuration of niphatesine D
- On the synthesis of pyrinodemin A. Part 1: The location of the olefin
- Genomic Discovery and Structure–Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors
- Abstract 2939: Discovery and synthesis of highly potent and selective small molecule inhibitors of the histone methyltransferase EZH2
- Abstract 5379: A potent EZH2 inhibitor exhibits long residence time and anti-tumor activity
- Synthesis of Marine Sponge Alkaloid Hachijodine B (Ia) and a Comment on the Structure of Ikimine B (Ib) and on the Absolute Configuration of Niphatesine D (Ic).
- Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 4-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-N-phenyl-2-morpholinecarboxamide
- Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-(3-Amino-1H-indazol-6-yl)-N4-ethyl-2,4-pyrimidinediamine
- CCDC 280107: Experimental Crystal Structure Determination
- CCDC 280106: Experimental Crystal Structure Determination
- Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl {(3R,6S)-1-[2-amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-3-piperidinyl}carbamate